Deep Chatterjee
Goethe University Frankfurt · 48 works · 813 citations · h-index 16
Top works
- Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases
- Design of Photocaged Puromycin for Nascent Polypeptide Release and Spatiotemporal Monitoring of Translation
- LRRK2 dynamics analysis identifies allosteric control of the crosstalk between its catalytic domains
- Modulating Androgen Receptor-Driven Transcription in Prostate Cancer with Selective CDK9 Inhibitors
- Design of Photocaged Puromycin for Nascent Polypeptide Release and Spatiotemporal Monitoring of Translation
- New pyrido[3,4-g]quinazoline derivatives as CLK1 and DYRK1A inhibitors: synthesis, biological evaluation and binding mode analysis
- Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanisms
- Nanobodies as allosteric modulators of Parkinson’s disease–associated LRRK2
- Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structures
- Characterization of the Simultaneous Decay Kinetics of Metarhodopsin States II and III in Rhodopsin by Solution‐State NMR Spectroscopy
- Nucleotide Binding, Evolutionary Insights, and Interaction Partners of the Pseudokinase Unc-51-like Kinase 4
- Characterization of the Simultaneous Decay Kinetics of Metarhodopsin States II and III in Rhodopsin by Solution‐State NMR Spectroscopy
- Structure and Biophysical Characterization of the S-Adenosylmethionine-dependent O-Methyltransferase PaMTH1, a Putative Enzyme Accumulating during Senescence of Podospora anserina
- Structural Aspects of LIMK Regulation and Pharmacology
- Lessons from LIMK1 enzymology and their impact on inhibitor design
- Illuminating the Dark: Highly Selective Inhibition of Serine/Threonine Kinase 17A with Pyrazolo[1,5- a ]pyrimidine-Based Macrocycles
- Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2
- Conformational plasticity of the ULK3 kinase domain
- Structure of LRRK1 and mechanisms of autoinhibition and activation
- PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domain